Browsing Centre for Immunobiology by Author "Tallarico, L"
Now showing items 1-1 of 1
-
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.
Foster, GR; Coppola, C; Derbala, M; Ferenci, P; Orlandini, A; Reddy, KR; Tallarico, L; Shiffman, ML; Ahlers, S; Bakalos, G (2016)BACKGROUND: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized ...